Detalhe da pesquisa
1.
Is physiotherapy in migraines known to sufferers? A cross-sectional study.
Neurol Sci
; 45(4): 1669-1674, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37966625
2.
Blood pressure monitoring in elderly migraineurs starting an anti-CGRP monoclonal antibody: a real-world prospective study.
Neurol Sci
; 2024 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38795273
3.
Migraine chronification as an allostatic disorder: a proof-of-concept study.
Neurol Sci
; 45(6): 2775-2782, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261154
4.
Gender-related stress factors and emotional perception in migraine: a structured online questionnaire in migraine patients and controls.
Neurol Sci
; 45(4): 1645-1654, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936018
5.
The evolutionary meaning of migraine.
Cephalalgia
; 43(12): 3331024231209303, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38041827
6.
Prevalence, natural history and dynamic nature of chronic headache and medication overuse headache in Italy: The SPARTACUS study.
Cephalalgia
; 43(4): 3331024231157677, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36950942
7.
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study.
Eur J Neurol
; 30(1): 224-234, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36097739
8.
Vessel-wall MRI in primary headaches: The role of neurogenic inflammation.
Headache
; 63(10): 1372-1379, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-35137395
9.
Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache.
Cephalalgia
; 42(7): 645-653, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135357
10.
Self-administered subcutaneous diclofenac sodium in acute migraine attack: A randomized, double-blind, placebo-controlled dose-finding pilot study.
Cephalalgia
; 42(10): 1058-1070, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35469478
11.
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study.
Eur J Neurol
; 29(4): 1198-1208, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34826192
12.
The ultimate guide to the anti-CGRP monoclonal antibodies galaxy.
Neurol Sci
; 43(9): 5673-5685, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35725856
13.
Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data.
Neurol Sci
; 43(6): 3823-3830, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35015202
14.
Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache.
Neurol Sci
; 43(2): 1273-1280, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224026
15.
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients.
J Headache Pain
; 23(1): 138, 2022 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316648
16.
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study.
J Headache Pain
; 23(1): 38, 2022 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305579
17.
Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study.
Headache
; 61(2): 363-372, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33337544
18.
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study.
Headache
; 61(9): 1351-1363, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34309862
19.
Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) project.
Headache
; 61(6): 936-950, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125953
20.
Anterior callosal angle correlates with gait impairment and fall risk in iNPH patients.
Acta Neurochir (Wien)
; 163(3): 759-766, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33438062